SBTX - ARS Pharmaceuticals Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

BOSTON, MA / ACCESSWIRE / September 20, 2023 / Block & Leviton is investigating ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) for potential securities law violations. Investors who have lost money in their ARS Pharmaceuticals investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://www.blockleviton.com/cases/spry.

What is this all about?

On September 19, 2023, the U.S. Food and Drug Administration (FDA) rejected ARS Pharmaceuticals epinephrine nasal spray, neffy, and requested additional safety and efficacy data in the complete response letter (CRL) issued to the Company.

Previously in May of 2023, ARS Pharmaceuticals' share price fluctuated around an FDA Advisory Committee (AdCom) meeting to review neffy. The FDA AdCom endorsed neffy on May 11, 2023.

Shares of ARS Pharmaceuticals stock dropped more than 55% in intraday trading on September 20, 2023.

Who is eligible?

Anyone who purchased ARS Pharmaceuticals, Inc. stock and has lost money may be eligible, whether or not they have sold their investment. Investors should contact Block & Leviton to learn more.

What is Block & Leviton doing?

Block & Leviton is investigating whether the Company committed securities law violations and may file an action to attempt to recover losses on behalf of investors who have lost money.

What should you do next?

If you've lost money on your investment, you should contact Block & Leviton to learn more via our case website, by email at cases@blockleviton.com, or by phone at (617) 398-5600.

Why should you contact Block & Leviton?

Block & Leviton is widely regarded as one of the leading securities class action firms in the country. We have obtained, and are dedicated to obtaining significant recoveries on behalf of defrauded investors through active litigation in the federal courts across the country. Many of the nation's top institutional investors hire us to represent their interests. You can learn more about us at our website, www.blockleviton.com, or call (617) 398-5600 or email cases@blockleviton.com with any questions.

This notice may constitute attorney advertising.

CONTACT:
BLOCK & LEVITON LLP
260 Franklin St., Suite 1860
Boston, MA 02110
Phone: (617) 398-5600
Email: cases@blockleviton.com
www.blockleviton.com

SOURCE: Block & Leviton LLP